sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
25-Oct-2014 01:38
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 76-100 out of 899.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 > >>

Public Release: 9-Sep-2014
Nature Communications
Weakness in malaria parasite fats could see new treatments
A new study has revealed a weak spot in the complex life cycle of malaria, which could be exploited to prevent the spread of the deadly disease, and may even lead to a vaccine. It found female malaria parasites put on fat differently to male ones, a process that can be used to develop drug targets.

Contact: Alex Maier
alex.maier@anu.edu.au
61-261-258-032
Australian National University

Public Release: 9-Sep-2014
PLOS Medicine
Prioritizing pregnant women in malaria endemic regions for bed nets from clinics
Donors, Ministries of Health, implementing agencies, and other partners should prioritize providing pregnant women in malaria endemic regions with long-lasting insecticide treated nets through antenatal care clinics to help prevent malaria and its adverse effects on mother and infant, according to experts from the UK and US, writing in this week's PLOS Medicine.
United States Agency for International Development, Johns Hopkins University Cooperative Agreement for the NetWorks Project

Contact: Maya Sandler
medicinepress@plos.org
PLOS

Public Release: 9-Sep-2014
PLOS Medicine
After 2 years on antiretroviral therapy, survival in South African patients meets rates from North America
Provided that therapy is started promptly, South Africans with HIV have chances of remaining alive beyond two years on antiretroviral therapy that are comparable to those of North American patients, according to new research in PLOS Medicine by Andrew Boulle of the University of Cape Town and colleagues.

Contact: Maya Sandler
medicinepress@plos.org
PLOS

Public Release: 8-Sep-2014
Nature Medicine
Rapid and durable protection against ebola virus with new vaccine regimens
One shot of an experimental vaccine made from two Ebola virus gene segments incorporated into a chimpanzee cold virus vector, called chimp adenovirus type 3 or ChAd3, protected all four macaque monkeys exposed to high levels of Ebola virus 5 weeks after inoculation, report National Institutes of Health scientists and their collaborators.
NIH/National Institute of Allergy and Infectious Diseases

Contact: NIAID Office of Communications
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 8-Sep-2014
Nature Immunology
Scientists reveal cell secret potentially useful for vaccines
Researchers open a new page in the immune system's playbook, discovering more chatter goes on among the body's infection fighters than was suspected.

Contact: Paula Brewer Byron
paulabyron@vt.edu
540-526-2027
Virginia Tech

Public Release: 8-Sep-2014
Canada funds 22 inventive ideas for better health in developing nations
A device that converts sound into symbols for display on eg. Google Glass, captioning conversations in real-time for deaf people and a sterile cover that enables the substitution of an everyday $100 power drill for a $30,000 orthopedic surgery unit in low-resource settings are among 22 projects to improve health in developing countries seed funded today by Canada.
Grand Challenges Canada

Contact: Terry Collins
tc@tca.tc
416-538-8712
Grand Challenges Canada

Public Release: 4-Sep-2014
Epidemiology & Infection
Use of dengue vaccine may cause short-term spikes in its prevalence
As researchers continue to work toward vaccines for serious tropical diseases such as dengue fever, experts caution in a new report that such vaccines will probably cause temporary but significant spikes in the disease in the years after they are first used.

Contact: Jan Medlock
jan.medlock@oregonstate.edu
Oregon State University

Public Release: 4-Sep-2014
Journal of Proteome Research
Finding new approaches for therapeutics against Ebola virus
Researchers from the University of Liverpool in collaboration with Public Health England have been investigating new ways to identify drugs that could be used to treat Ebola virus infection.
The University of Liverpool, Public Health England, the University of Bristol and the Health Protection Research Unit in Emerging and Zoonotic Infections.

Contact: Jamie Brown
jamie.brown@liverpool.ac.uk
44-151-794-2248
University of Liverpool

Public Release: 2-Sep-2014
eLife
New discovery could help turn antibiotic into antimalarial drug
Melbourne researchers are making progress towards new antimalarial drugs, after revealing how an antibiotic called emetine blocks the molecular machinery that produces the proteins required for malaria parasite survival.
Australian National Health and Medical Research Council, Australian Research Council, Wellcome Trust, Medical Research Council, Australia-Europe Malaria Research Cooperation, Human Frontier Science Program, Government of Victoria

Contact: Alan Gill
gill.a@wehi.edu.au
61-393-452-719
Walter and Eliza Hall Institute

Public Release: 2-Sep-2014
Drug that improves blood flow may help find cause of exercise intolerance in cystic fibrosis
A little white pill may help scientists learn why patients with cystic fibrosis have less exercise capacity than their peers, even if their lungs are relatively healthy.
National Institutes of Health, Cystic Fibrosis Foundation, Vertex Pharmaceuticals Inc.

Contact: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Georgia Regents University

Public Release: 2-Sep-2014
PLOS Medicine
Food supplements plus cash to poor families reduces rates of child malnutrition in Niger
In Niger, interventions that combined the distribution of supplementary food with a cash transfer to poor families prevented acute malnutrition in young children more effectively than strategies that relied on either cash transfer or supplementary food distribution alone, according to a study by international researchers published in this week's PLOS Medicine.
Medecins Sans Frontieres

Contact: Maya Sandler
medicinepress@plos.org
PLOS

Public Release: 1-Sep-2014
Proceedings of the National Academy of Sciences
Faster, cheaper tests for sickle cell
Harvard scientists have developed a new test for sickle cell disease that provides results in just 12 minutes and costs as little as 50 cents -- far faster and cheaper than other tests.

Contact: Peter Reuell
preuell@fas.harvard.edu
617-496-8070
Harvard University

Public Release: 31-Aug-2014
Nature Medicine
A new way to diagnose malaria
A research team from the Singapore-MIT Alliance for Research and Technology has developed a technique that can detect malarial parasite's waste in infected blood cells.
Singapore National Research Foundation

Contact: Sarah McDonnell
s_mcd@mit.edu
617-253-8923
Massachusetts Institute of Technology

Public Release: 31-Aug-2014
Lancet Infectious Diseases
New tuberculosis blood test in children is reliable and highly specific
A new blood test provides a fast and accurate tool to diagnose tuberculosis in children, a new proof-of-concept study shows. The newly developed test is the first reliable immunodiagnostic assay to detect active tuberculosis in children. The test features excellent specificity, a similar sensitivity as culture tests in combination with speed of a blood test. The promising findings are a major advance for the diagnosis of tuberculosis in children, particularly in tuberculosis-endemic regions.
European and Developing Countries Clinical Trials Partnership, German Federal Ministry of Education and Research, Swiss National Science Foundation

Contact: Klaus Reither
Klaus.Reither@unibas.ch
41-612-848-967
Swiss Tropical and Public Health Institute

Public Release: 29-Aug-2014
Cell Host & Microbe
Study reveals how Ebola blocks immune system
Researchers have identified one way the Ebola virus dodges the body's antiviral defenses, providing important insight that could lead to new therapies.
US Department of Energy

Contact: Brian Grabowski
media@anl.gov
630-252-1232
DOE/Argonne National Laboratory

Public Release: 29-Aug-2014
Nature
Leading Ebola researcher at UTMB says there's an effective treatment for Ebola
A leading US Ebola researcher from the University of Texas Medical Branch at Galveston has gone on record stating that a blend of three monoclonal antibodies can completely protect monkeys against a lethal dose of Ebola virus up to five days after infection, at a time when the disease is severe. Thomas Geisbert, professor of microbiology and immunology, has written an editorial for Nature discussing advances in Ebola treatment research.

Contact: Donna Ramirez
donna.ramirez@gmail.com
409-772-8791
University of Texas Medical Branch at Galveston

Public Release: 28-Aug-2014
Journal of Infectious Diseases
New analysis of old HIV vaccines finds potentially protective immune response
Applying the benefit of hindsight, researchers at Duke Medicine have reanalyzed the findings of two historic pediatric HIV vaccine trials with encouraging results. The vaccines had in fact triggered an antibody response -- now known to be associated with protection in adults -- that was previously unrecognized in the infants studied in the 1990s.
Duke University Center for AIDS Research, NIH/National Institute of Child Health and Human Development

Contact: Sarah Avery
sarah.avery@duke.edu
919-660-1306
Duke University Medical Center

Public Release: 28-Aug-2014
Ebola vaccine trials fast-tracked by international consortium
A candidate Ebola vaccine could be given to healthy volunteers in the UK, The Gambia and Mali as early as September, as part of an series of safety trials of potential vaccines aimed at preventing the disease that has killed more than 1,400 people in the current outbreak in West Africa.
Wellcome Trust, Medical Research Council, NIH/National Institute of Allergy and Infectious Disease, UK Department for International Development

Contact: Christopher Hardwick
chardwick@som.umaryland.edu
University of Maryland School of Medicine

Public Release: 28-Aug-2014
PLOS Pathogens
From bite site to brain: How rabies virus hijacks and speeds up transport in nerve cells
Rabies is usually transmitted through the bite of an infected animal into muscle tissue of the new host. From there, the virus travels all the way to the brain where it multiplies and causes the usually fatal disease. An article published on Aug. 28 in PLOS Pathogens sheds light on how the virus hijacks the transport system in nerve cells to reach the brain with maximal speed and efficiency.

Contact: Eran Perlson
eranpe@post.tau.ac.il
PLOS

Public Release: 27-Aug-2014
Gender & Society
Expression of privilege in vaccine refusal
Not all students returning to school this month will be up to date on their vaccinations. A new study conducted by Jennifer Reich, a researcher at the University of Colorado Denver, shows that the reasons why children may not be fully vaccinated depends on the class privilege of their mothers.

Contact: David Kelly
david.kelly@ucdenver.edu
303-315-6374
University of Colorado Denver

Public Release: 27-Aug-2014
ACM International Joint Conference on Pervasive and Ubiquitous Computing
New smartphone app can detect newborn jaundice in minutes
University of Washington engineers and physicians have developed a smartphone application that checks for jaundice in newborns and can deliver results to parents and pediatricians within minutes.
Coulter Foundation, National Science Foundation Graduate Research Fellowship

Contact: Michelle Ma
mcma@uw.edu
206-543-2580
University of Washington

Public Release: 27-Aug-2014
Science Translational Medicine
Malaria symptoms fade on repeat infections due to loss of immune cells, UCSF-led team says
Children who repeatedly become infected with malaria often experience no clinical symptoms with these subsequent infections, and a team led by UC San Francisco researchers has discovered that this might be due at least in part to a depletion of specific types of immune cells.
National Institutes of Health, US Centers for Disease Control and Prevention

Contact: Jeffrey Norris
jeffrey.norris@ucsf.edu
415-502-6397
University of California - San Francisco

Public Release: 27-Aug-2014
New England Journal of Medicine
Better health care as important as controlling risk factors for heart health
Keeping a healthy heart may have as much to do with the quality of health care you have available as it does you avoiding risk factors such as smoking, bad diet and little exercise.
Population Health Research Institute, Canadian Institutes of Health Research, and others

Contact: Veronica McGuire
vmcguir@mcmaster.ca
90-552-591-402-2169
McMaster University

Public Release: 26-Aug-2014
Proceedings of the National Academy of Sciences
Breakthrough antibacterial approach could resolve serious skin infections
In several cases, scientists found an ionic liquid was more efficacious on a pathogenic biofilm than a standard bleach treatment and exhibited minimal cytotoxicity effects on human cell lines (unlike bleach). This has excellent prospects for aiding antibiotic delivery to the pathogen through biofilm disruption.

Contact: Nancy Ambrosiano
nwa@lanl.gov
505-667-0471
DOE/Los Alamos National Laboratory

Public Release: 26-Aug-2014
Environment Systems & Decisions
What can 14th century Venice teach us about Ebola and other emerging threats?
The way in which the Italian city of Venice dealt with the outbreak of the plague in the 14th century holds lessons on how to even mitigate the consequences of today's emerging threats, like climate change, terrorism, and highly infectious or drug-resistant diseases. So says Dr. Igor Linkov of the US Army Engineer Research and Development Center, and a visiting professor of the Ca Foscari University in Italy.

Contact: Alexander K. Brown
alexander.brown@springer.com
212-620-8063
Springer Science+Business Media

Showing releases 76-100 out of 899.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 > >>